Cancer risk associated with CT imaging: quantifying the evidence, addressing misconceptions, and optimizing risk communication.

Since its development in the early 1970s, computed tomography (CT) has transformed diagnostic radiology. Offering high-resolution, three-dimensional imaging of internal structures, CT is now integral to the diagnosis of trauma, malignancy, infection, and vascular disease. Globally, the number of CT scans performed each year has grown exponentially, surpassing 70 million annually in the USA alone [ 1 ]. This exponential growth has led to increased scrutiny regarding the potential risks of ionizing radiation exposure. While the individual risk from a single scan is typically low, the cumulative effect at the population level, particularly among children and patients undergoing serial imaging, may contribute to a measurable increase in cancer incidence [ 1 ]. Moreover, data suggest that the rate of imaging is highest among patients with complex or chronic conditions, many of whom receive repeated scans across multiple care settings [ 1 ]. Simultaneously, misconceptions persist among both physicians and patients regarding the magnitude of these risks. Many clinicians underestimate the radiation dose associated with common CT studies, while patients are often unaware that ionizing radiation, even in small doses, can contribute to long-term malignancy risk [ 1 ]. This combination of overuse and underappreciation of risk underscores the need for comprehensive education and informed decision-making. This review aims to clarify the evidence behind CT-related cancer risk, explore the biological and epidemiological mechanisms underpinning this concern, and propose current and future strategies to mitigate harm without compromising clinical care.

While recent decades have seen substantial reductions in CT-related radiation doses, new technological frontiers are redefining what is possible in terms of dose minimization without sacrificing diagnostic performance. One of the most promising innovations is photon-counting computed tomography (PCCT), a cutting-edge technology that departs from traditional energy-integrating detectors by directly counting individual X-ray photons and categorizing them by energy level. Photon-counting detectors represent a transformative shift in CT hardware design, offering improved spectral accuracy and significantly lower exposure per scan compared to conventional energy-integrating detectors [ 12 ]. This method provides superior spatial resolution, enhanced tissue contrast, and markedly reduced image noise, all while allowing for significantly lower radiation exposure per scan [ 14 ]. Early clinical evaluations suggest that PCCT could reduce radiation doses by up to 40–70% in some applications, making it particularly promising for cardiothoracic and oncologic imaging, domains that often require high-resolution imaging and repeated follow-up studies. Ongoing trials are assessing the clinical utility of PCCT across a range of applications, including coronary artery disease, pulmonary embolism, and low-dose lung cancer screening. As the technology matures and becomes more commercially available, it may replace conventional CT systems in high-volume centers, shifting the standard of care toward ultra-low-dose imaging without compromising diagnostic accuracy [ 12 , 13 ]. However, as with any emerging technology, equitable access will be a challenge. Ensuring that PCCT is not limited to resource-rich academic centers will require policy advocacy, manufacturer partnerships, and strategic deployment in settings where vulnerable populations such as pediatric or chronically ill patients stand to benefit most. Recent systematic reviews and dose-response meta-analyses (2018–2024) have demonstrated statistically significant increases in cancer incidence at cumulative exposures beginning around 50–100 mSv [ 18 ]. These updated findings strengthen risk estimates formerly based largely on BEIR VII modeling. National efforts such as Image Gently® and Image Wisely® continue to expand with updated guidance for PCCT and AI-enabled imaging workflows, but mandatory radiation safety education for ordering clinicians remains limited and represents a critical policy opportunity. Increasing adoption of cumulative radiation dashboards and “radiation passports” enables clinicians to track lifetime exposure and guide safer imaging follow-up recommendations. The future of safe and effective CT imaging will increasingly rely on personalized, risk-adaptive protocols that consider a patient’s individual characteristics rather than relying on one-size-fits-all parameters. This approach aligns with broader trends in precision medicine and recognizes that not all patients carry the same radiation risk. Personalized imaging protocols would incorporate variables such as age, sex, body size, organ radiosensitivity, medical history, and cumulative imaging exposure to determine both the necessity of a scan and the ideal scanning parameters. For example, a 25-year-old woman undergoing repeat pelvic imaging for endometriosis would receive a different scan protocol and perhaps an MRI recommendation compared to a 75-year-old male with suspected bowel obstruction and minimal prior imaging history [ 17 ]. Machine learning algorithms and AI-based decision tools are already being developed to help automate this decision-making. These systems can pull data from the patient’s electronic health record including previous radiation dose history and suggest optimized scan settings or recommend alternative modalities. Over time, such tools could support safer, more consistent imaging decisions across clinicians and institutions. Incorporating cumulative dose tracking into personalized imaging is especially critical for patients with chronic conditions, cancer survivorship, or genetic susceptibility to radiation-related malignancies. By quantifying lifetime exposure and visualizing trends over time, clinicians can make more informed decisions about when to image, how often, and with what modality [ 17 ]. While technology will play a crucial role in minimizing radiation exposure, systemic change also depends on robust policy and educational frameworks. Technological innovations are only as effective as the people and systems that deploy them. For this reason, institutional, national, and global efforts to establish and enforce best practices are essential to future progress. At the institutional level, implementing comprehensive dose tracking systems is an actionable first step. These platforms enable clinicians to monitor cumulative radiation exposure for individual patients and alert providers when thresholds are approached. When integrated with clinical decision support tools, dose tracking systems can prompt real-time reconsideration of imaging orders, helping to prevent unnecessary repeat scans [ 19 ]. On a broader scale, national and international campaigns have proven instrumental in shifting cultural norms around imaging safety. Programs such as Image Gently® (focused on pediatric populations) and Image Wisely® (for adult care) have developed and disseminated evidence-based protocols, educational materials, and audit tools to promote responsible imaging practices. These initiatives have led to demonstrable improvements in dose awareness and protocol compliance in many institutions [ 19 ]. However, to create lasting cultural change, these efforts must be embedded in the foundations of medical education and professional development. Mandatory radiation safety training should be integrated into undergraduate medical education, residency training, and ongoing continuing medical education requirements. Such training should go beyond technical concepts and include modules on risk communication, patient-centered imaging, and ethical stewardship of technology [ 19 ]. By strengthening institutional accountability, fostering provider education, and advocating for standardized policy implementation, the medical community can cultivate a culture of radiation awareness and responsibility. These initiatives ensure that future advancements in imaging technology are matched by equally sophisticated practices in clinical judgment, patient communication, and health equity.

Computed tomography imaging stands as one of the most powerful diagnostic tools in modern medicine, enabling clinicians to detect disease rapidly, guide treatment, and save lives. Its clinical value is undeniable. Yet, with this power comes a responsibility to use it wisely. The cancer risk associated with CT is real, if small, and becomes more significant when viewed through the lens of cumulative exposure, patient vulnerability, and long-term public health. Reducing this risk does not require abandoning CT, but rather reimagining how it is used. This means investing in technologies that minimize dose, educating clinicians to better understand and communicate risk, and fostering a culture in which each scan is ordered with intention. It also means centering patient safety in institutional policies, clinical workflows, and medical education. The future of imaging lies in precision and the decisions that precede it. When applied with care and discernment, CT imaging is effective and responsible. It reflects a healthcare system that values both immediate answers and long-term outcomes. In this balance lies the true potential of modern medical imaging: to heal, to inform, and to do no harm.